Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972276priorityCriticalpatent/ECSP972276A/en
Publication of ECSP972276ApublicationCriticalpatent/ECSP972276A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
Se describe 3-3(aminobencilamino)-4-(3clorofenilmino)-1H-pirazolo [3,4-d] pirimidinade la fórmula I (gráfico), el compuesto de la fórmula I inhibe, en particular, la actividad de quinasa de tirosina del receptor para el factor de crecimiento epidérmico, y se puede utilizar, por ejemplo, como agente antitumoral, y en los casos de hiperproliferación epidérmica(psoriasis).Described 3-3 (aminobenzylamino) -4- (3-chlorophenylmino) -1H-pyrazolo [3,4-d] pyrimidine of formula I (graph), the compound of formula I inhibits, in particular, the activity of tyrosine kinase of the receptor for epidermal growth factor, and can be used, for example, as an antitumor agent, and in cases of epidermal hyperproliferation (psoriasis).
ECSP9722761997-10-011997-10-01
DERIVATIVES OF CONDENSED PIRAZOLE AND PROCESSED FOR ITS PREPARATION
ECSP972276A
(en)
2-AMINO-6-ANILINE-PURINE DERIVATIVES AND PROCEDURE AND NEW INTERMEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS THAT INCLUDE SUCH DERIVATIVES AND THE USE OF THESE DERIVATIVES AS MEDICINES.